| 690909 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
|
2020-06-09 |
|
|
| Ringversuchsbezeichnung |
(ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)) |
|
| 690914 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
|
2020-09-16 |
|
|
| Ringversuchsbezeichnung |
(Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112) |
|
| 794057 |
Australia |
RCPAQAP
RCPAQAP
|
PHLN: SARS-CoV-2 and other coronaviruses
PHLN: SARS-CoV-2 and other coronaviruses
|
2020-10-23 |
|
|
| Kommentar |
(laboratory testing platforms that are utilised in the whole genome sequencing of SARS-CoV-2.
Available) (free of charge to Australian public health laboratories that require the capability to test for SARS-CoV-2.) |
| Prüfeigenschaft |
(Diluted SARS-CoV-2 (inactivated)) (Diluted SARS-CoV-2 (inactivated)) |
| Prüfobjekt |
(Inactivated virus for Whole genome sequencing) |
| Ringversuchsbezeichnung |
(PHLN: SARS-CoV-2 and other coronaviruses) |
|
| 880833 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular panel of Respiratory Infections and Pneumonia
[EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias]
Clinical PT - Molecular panel of Respiratory Infections and Pneumonia
[EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias]
|
2023-05-29 |
|
|
| Prüfeigenschaft |
(Coronavírus (SARS-CoV-2)) (Respiratory Syncytial Virus) (Respiratory Syncytial Virus A) (Respiratory Syncytial Virus B) |
|
| 1009007 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva]
Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva]
|
2023-01-31 |
|
|
| Prüfeigenschaft |
(Molecular Biology - Coronavirus (SARS-CoV2): saliva) |
| Prüfobjekt |
(lyophilized cell suspension or lyophilized human saliva (virus inactivated)) |
| Ringversuchsbezeichnung (in Landessprache) |
(EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva) |
| Ringversuchsbezeichnung |
(Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva) |
|
| 947164 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation
[EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação]
Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation
[EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação]
|
2022-07-26 |
|
|
| Prüfeigenschaft |
(Coronavirus (SARS-CoV2): antigen research by automation) |
| Prüfobjekt |
(Lyophilized cell suspension (inactivated virus)) |
| Ringversuchsbezeichnung (in Landessprache) |
(EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação) |
| Ringversuchsbezeichnung |
(Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation) |
|
| 1347466 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - POCT Respiratory Infections Panel
[EP Clínico - POCT Painel para Infecções Respiratórias]
Clinical PT - POCT Respiratory Infections Panel
[EP Clínico - POCT Painel para Infecções Respiratórias]
|
2025-03-24 |
|
|
| Prüfeigenschaft |
(Coronavirus (SARS-CoV2): nasopharynx and oropharynx) (Respiratory Syncytial Virus (RSV)) |
|
| 1163321 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)]
Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)]
|
2024-04-16 |
|
|
| Kommentar |
(with currently circulating virus variants. Some of the samples can contain chemically inactivated) (avian influenza A viruses.
Note for laboratories from non-EU countries:
The shipment of sample) (INSTAND EQA schemes for the corresponding viruses.
The interdisciplinary, non-profit, scientific) |
| Prüfeigenschaft |
(influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated)) |
| Ringversuchsbezeichnung (in Landessprache) |
(Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)) |
| Ringversuchsbezeichnung |
(Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432)) |
|
| 1163304 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)]
Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431)
[Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)]
|
2024-04-16 |
|
|
| Kommentar |
(currently circulating virus variants. Some of the samples can contain chemically inactivated avian) (influenza A viruses.
Note for laboratories from non-EU countries:
The shipment of sample materials) (, we refer to the INSTAND EQA schemes for the corresponding viruses.
The interdisciplinary, non) |
| Prüfeigenschaft |
(incl. avian influenza A viruses, parecho, parainfluenza, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated), respectively) (respiratory adeno, boca, corona, entero, human metapneumo, human rhino, influenza A and B viruses) |
| Ringversuchsbezeichnung (in Landessprache) |
(Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)) |
| Ringversuchsbezeichnung |
(Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431)) |
|
| 1163345 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – SARS-CoV-2 sequence analysis (417)
[Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)]
Virus Genome Detection – SARS-CoV-2 sequence analysis (417)
[Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)]
|
2024-04-16 |
|
|
| Kommentar |
(Please note:
Starting in 2024, only results of SARS-CoV-2 sequence analyses for SARS-CoV-2) |
| Prüfeigenschaft |
(Differentiation of SARS-CoV-2 variants with clinical relevance using whole genome sequencing) |
| Ringversuchsbezeichnung (in Landessprache) |
(Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)) |
| Ringversuchsbezeichnung |
(Virus Genome Detection – SARS-CoV-2 sequence analysis (417)) |
|
| 1163338 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – SARS-CoV-2 (409)
[Virusgenom-Nachweis - SARS-CoV-2 (409)]
Virus Genome Detection – SARS-CoV-2 (409)
[Virusgenom-Nachweis - SARS-CoV-2 (409)]
|
2024-04-16 |
|
|
| Prüfeigenschaft |
(The sample set contains defined samples with SARS-CoV-2 (full virus, inactivated) and, if necessary) (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV-2) |
| Ringversuchsbezeichnung (in Landessprache) |
(Virusgenom-Nachweis - SARS-CoV-2 (409)) |
| Ringversuchsbezeichnung |
(Virus Genome Detection – SARS-CoV-2 (409)) |
|
| 1160040 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Antigen Detection – SARS-CoV-2 (Ag) (410)
[Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)]
Virus Antigen Detection – SARS-CoV-2 (Ag) (410)
[Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)]
|
2024-04-16 |
|
|
| Kommentar |
(samples with antigen from SARS-CoV-2 (inactivated) and, if necessary, samples with antigen from human) (immunoassays for the detection of SARS-CoV-2 antigen.
The interdisciplinary, non-profit) |
| Prüfeigenschaft |
(SARS-CoV-2 antigen) |
| Ringversuchsbezeichnung (in Landessprache) |
(Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)) |
| Ringversuchsbezeichnung |
(Virus Antigen Detection – SARS-CoV-2 (Ag) (410)) |
|
| 1169419 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Immunology – SARS-CoV-2 (Ab) (416)
[Virusimmunologie - SARS-CoV-2 (Ak) (416)]
Virus Immunology – SARS-CoV-2 (Ab) (416)
[Virusimmunologie - SARS-CoV-2 (Ak) (416)]
|
2024-05-14 |
|
|
| Prüfeigenschaft |
(Anti-SARS-CoV-2 total (without differentiation of IgG, IgA and IgM)) (Anti-SARS-CoV-2 IgG) (Anti-SARS-CoV-2 IgG avidity) (Anti-SARS-CoV-2 IgA) (Anti-SARS-CoV-2 IgM (not certified)) |
| Ringversuchsbezeichnung (in Landessprache) |
(Virusimmunologie - SARS-CoV-2 (Ak) (416)) |
| Ringversuchsbezeichnung |
(Virus Immunology – SARS-CoV-2 (Ab) (416)) |
|
| 437169 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340)
[Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)]
Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340)
[Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)]
|
2024-04-16 |
|
|
| Prüfeigenschaft |
(Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV) (Option for differentiaton between SARS-CoV-2, MERS-CoV and other human coronaviruses (samples which) (contain SARS-CoV-2 and MERS-CoV, repectively, are inactivated) |
| Ringversuchsbezeichnung (in Landessprache) |
(Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)) |
| Ringversuchsbezeichnung |
(Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340)) |
|
| 1271562 |
Hungary |
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
|
Virus serology: SARS-CoV-2
[Vírus szerológia: SARS-CoV-2]
Virus serology: SARS-CoV-2
[Vírus szerológia: SARS-CoV-2]
|
2024-10-08 |
|
|
| Kommentar |
(The content of the scheme: SARS-CoV-2 antibody (IgG-, IgG-S, IgG-N, IgM, IgA, total antibody) |
| Prüfeigenschaft |
(Anti-SARS-CoV-2 total (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-S (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-N (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgM (OD, S/CO, quantitative, evaluation)) |
| Ringversuchsbezeichnung (in Landessprache) |
(Vírus szerológia: SARS-CoV-2) |
| Ringversuchsbezeichnung |
(Virus serology: SARS-CoV-2) |
|
| 1271426 |
Hungary |
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
|
Virus nucleic acid determination: SARS-CoV-2
[Vírus nukleinsav meghatározás: SARS-CoV-2]
Virus nucleic acid determination: SARS-CoV-2
[Vírus nukleinsav meghatározás: SARS-CoV-2]
|
2024-11-25 |
|
|
| Kommentar |
(amplification techniques (NAT) for qualitative determination of SARS-CoV-2 virus.
Qualitative results are) |
| Ringversuchsbezeichnung (in Landessprache) |
(Vírus nukleinsav meghatározás: SARS-CoV-2) |
| Ringversuchsbezeichnung |
(Virus nucleic acid determination: SARS-CoV-2) |
|
| 706310 |
Portugal |
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
|
SARS-CoV-2, molecular detection
[SARS-CoV-2, molecular detection]
SARS-CoV-2, molecular detection
[SARS-CoV-2, molecular detection]
|
2024-03-13 |
|
|
| Prüfeigenschaft |
(SARS-CoV-2 virus) |
| Ringversuchsbezeichnung (in Landessprache) |
(SARS-CoV-2, molecular detection) |
| Ringversuchsbezeichnung |
(SARS-CoV-2, molecular detection) |
|
| 134427 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Water Microbiology Scheme - (QWAS)
Water Microbiology Scheme - (QWAS)
|
2021-03-01 |
|
|
| Prüfeigenschaft |
(SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial)) |
| Prüfmethode |
(2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix) (0 to 10000 virus copies per ml) |
|
| 769005 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
SARS-CoV-2 Proficiency Testing Scheme
SARS-CoV-2 Proficiency Testing Scheme
|
2022-05-04 |
|
|
| Prüfeigenschaft |
(SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome) |
| Prüfobjekt |
(SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples) |
| Ringversuchsbezeichnung |
(SARS-CoV-2 Proficiency Testing Scheme) |
|
| 1144039 |
United Kingdom |
Weqas
Weqas
|
POCT Respiratory Virus
[POCT Respiratory Virus]
POCT Respiratory Virus
[POCT Respiratory Virus]
|
2024-10-01 |
|
|
| Kommentar |
(targeted for Influenza A (and subtypes) Influenza B, SARS-Cov-2, and Respiratory Syncytial Virus) (), influenza B, RSV, SARS-Cov-2 or no virus. A range of differing viral loads are distributed including) (virus in a stabilising buffer which may contain Influenza A (either / both H1N1 and H3N2 subtypes) (the laboratory / POCT site to correctly identify the virus (es) present in the sample, the) (sensitivities of the methods / devices, are also considered. A correct identification of the virus (es) is) |
| Prüfeigenschaft |
(SARS-CoV-2 Ag (RNA)) |
| Prüfobjekt |
(Buffered material spiked with inactivated virus) |
| Ringversuchsbezeichnung (in Landessprache) |
(POCT Respiratory Virus) |
| Ringversuchsbezeichnung |
(POCT Respiratory Virus) |
|
